相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
Marta Alvarez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Kristina M. Brooks et al.
PHARMACOTHERAPY (2019)
A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
Tracy Taylor et al.
SCIENTIFIC REPORTS (2019)
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort
S. Modica et al.
HIV MEDICINE (2019)
Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
Hezhao Ji et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing
Philip L. Tzou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children
Joseph Fokam et al.
MEDICINE (2018)
Assessment of Transmitted HIV-1 Drug Resistance Mutations Using Ultra-Deep Pyrosequencing in a Turkish Cohort
Uluhan Sili et al.
CURRENT HIV RESEARCH (2018)
Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors
Ronit R. Dalmat et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus
Hezhao Ji et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure
Fred Kyeyune et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
HIV Drug Resistance Testing by High-Multiplex Wide Sequencing on the MiSeq Instrument
H. R. Lapointe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
J. D. Baxter et al.
HIV MEDICINE (2015)
Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants
Kim Thys et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing
Alessandro Cozzi-Lepri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing
Christian Pou et al.
CLINICAL INFECTIOUS DISEASES (2014)
Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries
Halime Ekici et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing
Birgitte B. Simen et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
Dawn M. Dudley et al.
RETROVIROLOGY (2014)
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
Kachit Choopanya et al.
LANCET (2013)
Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool
Conan K. Woods et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance
Dawn M. Dudley et al.
PLOS ONE (2012)
Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study
David Dolling et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy
Derrick D. Goodman et al.
AIDS (2011)
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis
Jonathan Z. Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors
Vici Varghese et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes
Birgitte B. Simen et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use
Thuy Le et al.
PLOS ONE (2009)
Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance
Chunlin Wang et al.
GENOME RESEARCH (2007)
Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-base analysis of diverse human immunodeficiency virus type 1 strains
SH Eshleman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
分享论文
